ArticleEvidence-based medicine2011

Carrying one or two reduced-function CYP2C19 alleles is associated with an increased risk of major adverse cardiovascular events in people undergoing percutaneous coronary intervention and treated with clopidogrel.

Andrea H Ramirez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.